NCT04199390 is a NA clinical trial of total hip arthroplasty in Hip Osteoarthritis, sponsored by Orthopedic One.

Who is sponsoring NCT04199390?

NCT04199390 is sponsored by Orthopedic One.

What drugs are being tested in NCT04199390?

Interventions in NCT04199390: total hip arthroplasty.

What condition does NCT04199390 study?

NCT04199390 studies Hip Osteoarthritis, Surgery.

Is NCT04199390 still recruiting?

NCT04199390 is currently completed. Last updated 13 December 2019.

Last reviewed 2019-12-13 · How we verify

NCT04199390

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Therapy Following Total Hip Arthroplasty

Completed NA Last updated 13 December 2019

What this trial tests

NA trial testing total hip arthroplasty in Hip Osteoarthritis in 130 participants. Completed in 7 October 2019.

Timeline

31 July 2018

Primary endpoint
7 October 2019

7 October 2019

Quick facts

Lead sponsor	Orthopedic One
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	130
Start date	31 July 2018
Primary completion	7 October 2019
Estimated completion	7 October 2019
Sites	1 location across United States

Drugs / interventions tested

total hip arthroplasty

Conditions studied

Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
Surgery — all drugs for Surgery →

Sponsor

Orthopedic One

Who can join

Adults 18 to 75, any sex, with Hip Osteoarthritis or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

130 patients undergoing primary unilateral total hip arthroplasty through anterior approach were enrolled and randomized into one of two groups. One group received standard of care clinic-based physical therapy postoperatively (clinic PT) while the other group underwent progressive home-based exercises to do after surgery (home PT). Patient surveys with Hip Osteoarthritis Outcome Scores (HOOS) and SF12v2 scores for both groups were obtained before surgery as well as 6, 14, and 24 weeks postop. Patients had the option to crossover into the other study group at their 6-week follow-up visit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of total hip arthroplasty

Trials testing the same drug.

NCT05044767 — Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty · recruiting
NCT06176612 — In Patients With Hip Dysplasia, Mid-Term Lower Extremities and Spine After Hip Arthroplasty Natural Course · NA · completed
NCT03492684 — Superior Gluteal Neuropathy -Total Hip Arthroplasty · unknown
NCT03428672 — Quantitative Analysis of Global Proteome in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture · NA · unknown
NCT06360835 — Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases) · completed

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
NCT07327931 — PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults · NA · recruiting
NCT07288983 — PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery · NA · recruiting
NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
NCT07347041 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04199390 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthopedic One
Last refreshed: 13 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04199390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing